
Vildagliptin (50mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metsmall V 1000 Tablet is a prescription medication indicated for the treatment of type 2 diabetes mellitus. This once-daily tablet combines the metformin and vildagliptin salts to provide a comprehensive approach to glucose control. Metformin, a biguanide, works by reducing the amount of glucose produced by the liver and improving insulin sensitivity, while vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, slows the inactivation of incretin hormones, which in turn enhances insulin secretion and glucose disposal. The synergistic effects of these two salts result in improved glycemic control, reduced glucose variability, and enhanced patient adherence. Metsmall V 1000 Tablet is available in a once-daily tablet formulation, making it a convenient and effective treatment option for patients with type 2 diabetes. As with all medications, patients should be monitored for potential side effects, including gastrointestinal disturbances, headaches, and increased risk of lactic acidosis, and should follow the recommended dosage and administration guidelines to ensure optimal therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metsmall V 1000 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metsmall V 1000 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Metsmall V 1000 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metsmall V 1000 Tablet may be needed. Please consult your doctor.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metsmall V 1000 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Metsmall V 1000 Tablet

Metformin (1000mg) + Vildagliptin (50mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metsmall V 1000 Tablet is a prescription medication indicated for the treatment of type 2 diabetes mellitus. This once-daily tablet combines the metformin and vildagliptin salts to provide a comprehensive approach to glucose control. Metformin, a biguanide, works by reducing the amount of glucose produced by the liver and improving insulin sensitivity, while vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, slows the inactivation of incretin hormones, which in turn enhances insulin secretion and glucose disposal. The synergistic effects of these two salts result in improved glycemic control, reduced glucose variability, and enhanced patient adherence. Metsmall V 1000 Tablet is available in a once-daily tablet formulation, making it a convenient and effective treatment option for patients with type 2 diabetes. As with all medications, patients should be monitored for potential side effects, including gastrointestinal disturbances, headaches, and increased risk of lactic acidosis, and should follow the recommended dosage and administration guidelines to ensure optimal therapeutic outcomes.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metsmall V 1000 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Metsmall V 1000 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Metsmall V 1000 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metsmall V 1000 Tablet may be needed. Please consult your doctor.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metsmall V 1000 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Metsmall V 1000 Tablet













